To appear in Best of the Brokers, email your research to email@example.com
Cantor Fitzgerald tells investors to “sell” the retailer ahead of a trading update tomorrow. Dropping its target price from 200p to 151p, the broker said the children’s retailer is “running out of options” with sales dropping at home and overseas.
UBS has downgraded the pharma group from “buy” to “neutral” as the stock nears its price target of 1,700p. The broker sees continued growth for the firm, particularly if it follows through with ambitions to buy up businesses in Russia.